Key result
PFO closure for isolated TIA shows no significant difference in recurrent thromboembolism vs stroke.
Why the study?
Data regarding the benefit of PFO closure in patients with PFO-related TIA compared with ischemic stroke remain limited.
Does percutaneous PFO closure for isolated PFO-related TIA result in different rates of recurrent stroke, TIA, or peripheral arterial embolism compared to PFO closure for PFO-related ischemic stroke?
Cohort (n=4,672)
Yes
Does percutaneous PFO closure for isolated PFO-related TIA result in different rates of recurrent stroke, TIA, or peripheral arterial embolism compared to PFO closure for PFO-related ischemic stroke?
Following percutaneous PFO closure, the overall composite risk of stroke, TIA, or peripheral embolism did not significantly differ between patients presenting with an index TIA versus an index stroke, although patients with an index TIA experienced a significantly higher rate of recurrent TIA.
Should not yet alter PFO closure decisions by index event; leaves open whether isolated TIA independently predicts higher recurrence in observational cohorts.
Background Data regarding the benefit of patent foramen ovale (PFO) closure in patients with PFO-related transient ischemic attack (TIA), as compared with ischemic stroke, remain limited. Purpose To compare clinical outcomes after PFO closure according to the type of index cerebrovascular event (stroke ± TIA vs. isolated TIA). Methods We included patients who underwent PFO closure for secondary prevention of stroke or TIA in the international AIR FORCE registry across 31 centers in France, Italy, and the Netherlands between 2001 and 2025. The primary endpoint was the occurrence of center-reported stroke, TIA, or peripheral arterial embolism during follow-up. Cumulative incidence up to 3 years was estimated using Kaplan–Meier methods, and associations between indication for PFO closure (TIA vs. ischemic stroke) and outcomes were assessed over the entire follow-up using adjusted Cox proportional hazards models. Results A total of 4672 patients were included. Baseline characteristics are presented in Table 1. After a median follow-up of 1.0 years [0.1–2.8], no significant association was observed between the indication for PFO closure and the composite outcome (aHR 1.52, 95% CI 0.83–2.77), with corresponding 3-year risks of 4.12% [2.08–8.08] in patients with only TIA and 1.80% [1.28–2.52] in patients with prior stroke (figure 1). Similarly, no significant association was observed for stroke or peripheral arterial embolism (aHR 0.73, 95% CI 0.26–2.04). In contrast, a significant association was observed for TIA recurrence (aHR 3.49, 95% CI 1.68–7.27), with higher 3-year risks in patients with only TIA (3.62% [1.71–7.59] vs. 0.72% [0.41–1.25]). Conclusion In this large international registry, the risk of stroke, TIA, or peripheral arterial embolism after PFO closure did not differ between patients with a PFO-related TIA versus those with a PFO-related stroke as the index event. However, patients with index TIA had a significantly higher risk of TIA recurrence, suggesting the involvement of other causes.
No takes yet. Share an insight, caveat, or question.
Guedeney et al. (2026) conducted a cohort in Patent foramen ovale-related transient ischemic attack or ischemic stroke (n=4,672). PFO closure for isolated transient ischemic attack (TIA) vs. PFO closure for ischemic stroke (± TIA) was evaluated on Composite of center-reported stroke, TIA, or peripheral arterial embolism (aHR 1.52, 95% CI 0.83-2.77). PFO closure for isolated TIA vs stroke showed no significant difference in composite stroke, TIA, or peripheral embolism (4.12% vs 1.80%; aHR 1.52, 95% CI 0.83-2.77).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: